Euglycaemic diabetic ketoacidosis in a 43-year-old woman with type 2 diabetes mellitus on SGLT-2 inhibitor (empagliflozin)

Drug Ther Bull. 2021 Jun;59(6):93-95. doi: 10.1136/dtb.2021.235117rep. Epub 2021 Jan 28.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Diabetes Mellitus, Type 2 / drug therapy*
  • Diabetic Ketoacidosis / chemically induced*
  • Female
  • Humans
  • Sodium-Glucose Transporter 2 Inhibitors / adverse effects*
  • Sodium-Glucose Transporter 2 Inhibitors / therapeutic use

Substances

  • Sodium-Glucose Transporter 2 Inhibitors